An SGLT2 inhibitor with demonstrated evidence of benefit is recommended for individuals with HF with reduced ejection fraction [61,62] or HF with preserved ejection fraction [63,64] [Grade A, Level 1A for dapagliflozin or empagliflozin]
These criteria are more stringent than the previous Rotterdam criteria, aiming to identify women with higher metabolic risks associated with PCOS (131)
At the same time, they are more likely to engage in regular exercise and use vitamins compared to before starting GLP-1 drugs
Las reacciones locales ms reportadas incluyen: Eritema (enrojecimiento) Inflamacin leve Hematoma pequeo Prurito Sensibilidad local En estudios clnicos, las reacciones en el sitio de inyeccin fueron generalmente leves y autolimitadas
The way Wegovy and Ozempic work in the body are essentially the same
For most people, taking 2 g or less per day is relatively safe and unlikely to cause serious side effects